Hireche, K.; Lounes, Y.; Bacri, C.; Solovei, L.; Marty-Ané, C.; Canaud, L.; Alric, P.
VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis. Cancers 2023, 15, 414.
https://doi.org/10.3390/cancers15020414
AMA Style
Hireche K, Lounes Y, Bacri C, Solovei L, Marty-Ané C, Canaud L, Alric P.
VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis. Cancers. 2023; 15(2):414.
https://doi.org/10.3390/cancers15020414
Chicago/Turabian Style
Hireche, Kheira, Youcef Lounes, Christophe Bacri, Laurence Solovei, Charles Marty-Ané, Ludovic Canaud, and Pierre Alric.
2023. "VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis" Cancers 15, no. 2: 414.
https://doi.org/10.3390/cancers15020414
APA Style
Hireche, K., Lounes, Y., Bacri, C., Solovei, L., Marty-Ané, C., Canaud, L., & Alric, P.
(2023). VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis. Cancers, 15(2), 414.
https://doi.org/10.3390/cancers15020414
